XAIR · Beyond Air, Inc.
$6.32
-0.61 (-8.74%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management believes these factors raise substantial doubt about the Company’s ability to meet its obligations with cash on hand and concluded that the Company will require additional funding within one year from the date these financial statements are issued. Management is confident that the efforts to arrange financing, while not assured, will enable them to meet the Company’s obligations.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.05M
Shares
957,631
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$7.68M
+107.3%
FY2026
Net Income
-$33.25M
+28.7%
FY2026
Gross Margin
3.28%
+48.2pp
FY2026
Operating Margin
-378.23%
+823.8pp
FY2026
Diluted EPS
-$80.20
+70.9%
FY2026
Operating Cash Flow
-$18.14M
+52.5%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $7.69M | $7.68M | $3.71MG | $1.16M | — | — | $873K | $1.39M | $7.72M | — | — | — | |
| $378K | $303K | $705K | — | — | — | — | — | — | — | — | — | |
| $2.38M | — | — | — | — | — | — | — | — | $6.98M | -$6.98M | — | |
| $7.37M | $7.43M | $5.37M | $2.47M | $555K | — | — | — | — | — | — | — | |
| $321K | $252K | -$1.66M | -$1.31M | -$555K | — | — | — | — | — | — | — | |
| — | 3.28% | -44.89% | -112.77% | — | — | — | — | — | — | — | — | |
| $9.11M | $10.24M | $16.86M | $24.36M | $16.81M | $11.8M | $12.62M | $10.65M | $3.93M | $4.64M | $4.44M | — | |
| — | — | — | $37.34M | $34.69M | $18.41M | $10.47M | $8.88M | $6.85M | $5.31M | $6.63M | $67.15K | |
| $19.25M | $19.06M | $26.02M | $37.34M | — | — | — | — | — | — | — | — | |
| — | $204K | $205K | $205K | $205K | $38K | — | — | — | — | — | — | |
| $3.1M | $3.1M | $3M | $1.8M | $600K | $314K | $173K | $77.17K | $64.79K | — | — | — | |
| $28.36M | $29.3M | $42.87M | $61.7M | $51.5M | $40.71M | — | — | — | — | — | $67.15K | |
| -$28.04M | -$29.04M | -$44.54M | -$63.01M | -$52.06M | -$40.71M | -$22.21M | -$18.14M | -$3.06M | $9.94M | -$11.07M | -$67.15K | |
| — | -378.23% | -1202.08% | -5436.24% | — | — | -2544.56% | -1305.08% | -39.6% | — | — | — | |
| -$24.94M | -$25.94M | -$41.54M | -$61.21M | -$51.46M | -$40.4M | -$22.04M | -$18.06M | -$2.99M | — | — | — | |
| $4.46M | $3.52M | $3.02M | $2.91M | $30K | $775K | $642K | $30.54K | $1506 | — | — | $895 | |
| -$6.37M | -$5.29M | -$3.94M | -$1.29M | -$7.34M | -$3.35M | -$661K | -$1.95M | -$3.5M | -$772.68K | -$6.98M | — | |
| -$34.41M | -$34.33M | -$48.48M | -$64.3M | -$59.4M | -$44.06M | -$22.88M | -$20.1M | -$6.59M | $18.04M | -$18.04M | — | |
| — | — | — | — | — | — | — | -$154.3K | — | $27K | $27K | — | |
| -$33.18M | -$33.25M | -$46.63M | -$60.24M | -$55.82M | -$43.18M | -$22.88M | -$19.94M | -$6.56M | -$10.72M | -$18.04M | -$68.25K | |
| — | -432.99% | -1258.43% | -5197.76% | — | — | -2620.27% | -1434.61% | -84.91% | — | — | — | |
| -$917K | -$1.09M | -$1.85M | -$4.05M | -$3.59M | -$882K | — | — | — | — | — | — | |
| — | — | — | — | — | — | -$22.54M | -$20.46M | -$6.56M | -$18M | -$18.04M | — | |
| — | -$33.06M | -$46.67M | — | — | — | — | — | -$6.56M | -$18.04M | -$18.04M | — | |
| USD/shares | — | -$80.20 | -$275.40 | -$728.00 | -$744.00 | -$672.00 | -$508.00 | — | -$308.00 | -$1,204.00 | — | — |
| USD/shares | — | -$80.20 | -$275.40 | -$728.00 | -$744.00 | — | — | — | -$308.00 | -$1,204.00 | — | — |
| shares | — | 415.05K | 169.27K | 82.9K | 74.93K | 64.17K | 45.01M | 28.77K | 21.25K | 15.98K | 15.01K | 258 |
| shares | — | 415.05K | 169.27K | 82.9K | 74.93K | — | 45.01K | 28.77K | 21.25K | 15.98K | 15.01K | 258 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2017–FY2019: $75K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.90×
Peer median 1.53×
EV/EBIT
—
Peer median 23.82×
P/E (TTM)
—
Peer medians compare against the 53 similar-size Medical Devices companies (of 148 listed).
Valuation over time computed as of each quarter's filing date
Key facts
CIK
1641631
CUSIP
08862L301
13F (30d)
27 filings
26 filers
Visit website
Investor relations